Add to ORKGAM: Patients with Fabry disease (FD), a genetic disorder caused by lysosomal a-galactosidase-A enzyme deficiency and characterized by a systemic accumulation of globotriaosylceramides, present high prevalence of subclinical hypothyroidism. The pathogenic mechanism is thought not to be related to anti-thyroid autoimmunity and may be dependent by intra-thyroid lipid accumulation. In this study, it was investigated whether thyroid function recovers in FD after long-term enzyme replacement therapy (ERT)
Fabry disease is an X-linked lysosomal disorder that results from a deficiency of the lysosomal enzy...
The long-term effects of enzyme-replacement therapy (ERT) in Fabry disease are unknown. Thus, the ai...
: Fabry disease is a rare X-linked disease characterized by deficient expression and activity of alp...
AM: Patients with Fabry disease (FD), a genetic disorder caused by lysosomal a-galactosidase-A enzym...
Abstract. Fabry disease (FD) is an X-linked recessive disorder caused by lysosomal α-galactosidase A...
BACKGROUND: Fabry disease (FD) is a genetic disorder caused by lysosomal alpha-galactosidase-A defic...
BACKGROUND: Fabry disease (FD) is a genetic disorder caused by lysosomal alpha-galactosidase-A def...
Fabry disease (FD) is a rare X-linked recessive glycosphingolipid-storage disorder caused by deficie...
Fabry disease is treated by two-weekly infusions with a-galactosidase A. which is deficient in this ...
Fabry disease is a rare X-linked lysosomal storage disorder due to mutations in the GLA gene causing...
Enzyme replacement therapy (ERT) has been used to treat Fabry disease - a progressive lysosomal stor...
To determine the effectiveness of enzyme replacement therapy (ERT) for adults and children with Fabr...
Anderson-Fabry disease is an X-linked lysosomal storage disorder resulting from the deficiency of th...
Fabry disease is an X-linked inherited condition due to the absence or reduction of alpha-galactos...
Pathogenesis: Fabry disease is an inherited lysosomal storage disorder caused by deficiency of the e...
Fabry disease is an X-linked lysosomal disorder that results from a deficiency of the lysosomal enzy...
The long-term effects of enzyme-replacement therapy (ERT) in Fabry disease are unknown. Thus, the ai...
: Fabry disease is a rare X-linked disease characterized by deficient expression and activity of alp...
AM: Patients with Fabry disease (FD), a genetic disorder caused by lysosomal a-galactosidase-A enzym...
Abstract. Fabry disease (FD) is an X-linked recessive disorder caused by lysosomal α-galactosidase A...
BACKGROUND: Fabry disease (FD) is a genetic disorder caused by lysosomal alpha-galactosidase-A defic...
BACKGROUND: Fabry disease (FD) is a genetic disorder caused by lysosomal alpha-galactosidase-A def...
Fabry disease (FD) is a rare X-linked recessive glycosphingolipid-storage disorder caused by deficie...
Fabry disease is treated by two-weekly infusions with a-galactosidase A. which is deficient in this ...
Fabry disease is a rare X-linked lysosomal storage disorder due to mutations in the GLA gene causing...
Enzyme replacement therapy (ERT) has been used to treat Fabry disease - a progressive lysosomal stor...
To determine the effectiveness of enzyme replacement therapy (ERT) for adults and children with Fabr...
Anderson-Fabry disease is an X-linked lysosomal storage disorder resulting from the deficiency of th...
Fabry disease is an X-linked inherited condition due to the absence or reduction of alpha-galactos...
Pathogenesis: Fabry disease is an inherited lysosomal storage disorder caused by deficiency of the e...
Fabry disease is an X-linked lysosomal disorder that results from a deficiency of the lysosomal enzy...
The long-term effects of enzyme-replacement therapy (ERT) in Fabry disease are unknown. Thus, the ai...
: Fabry disease is a rare X-linked disease characterized by deficient expression and activity of alp...